Skip to content

Outcomes of Elderly Patients Admitted to the Intensive Care Unit With Severe Acute Cholangitis

Prognostic Factors Associated With Mortality Within 6 Months Among Critically Ill Elderly Patients Admitted to the Intensive Care Unit With Severe Acute Cholangitis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03831529
Acronym
ANGIOCHOLREA
Enrollment
204
Registered
2019-02-06
Start date
2018-06-18
Completion date
2019-01-15
Last updated
2019-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cholangitis Infective, Elderly Person

Keywords

critically ill, mortality, outcome, treatment intensity level

Brief summary

The aging of the population goes along with an increased demand for intensive care among very elderly patients (above 75-80 years old). At the same time, there is a decline in the supply of intensive care units (ICU). The 1-year mortality of patients above 80 years old in ICU ranged from 40 to 70%. Moreover, many survivors suffer from long-term sequelae as poor quality of life, cognitive impairment and functional disability. It is unclear under what conditions older patients may benefit from ICU admission. Cholangitis frequently occured in older patient. Moreover, severe acute cholangitis is a potentially life threatening disease characterized by a biliary obstruction and an infection of the bile possibly evolving towards systemic infection, shock and death. Because of its potential rapid reversibility of symptom thanks to early intravenous antibiotics and biliary decompression with drainage, old patients suffering from acute cholangitis are easily admitted to intensive care unit. To date, there is a lack of data about the outcome in this population admitted to the intensive care unit with acute cholangitis. The aim of the current study is to describe the outcomes in elderly patients (\> 75 years old) admitted to the ICU with acute cholangitis and to identify prognostics factors associated with long term mortality (6 months).

Interventions

None listed

Sponsors

Central Hospital, Nancy, France
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum

Inclusion criteria

* \> 65 years old * ICU admission for acute cholangitis * follow up in the same center after the ICU stay

Exclusion criteria

* none

Design outcomes

Primary

MeasureTime frameDescription
mortality180 daysrate of survivors and non survivors

Secondary

MeasureTime frameDescription
factors associated with 6 months mortality (underlying condition)Day 1Functional status : presence or absence of denutrition defined by a BMI \< 19 kg/m2 and/or albuminemia \< 30 g/l and/or loss of weight \> 5% during the last month (or \> 10% during the last three months)
factors associated with 6 months mortality (severity score)Day 1Simplified Acute Physiology Score 2 Minimum value : 0 / Maximun value 163
factors associated with 6 months mortality (Presence of hemodynamic failure)Up to 7 daysinfusion of catecholamine (ie norepinephrine) during the ICU stay, yes or not
mortality90 daysrate of survivors and non survivors
factors associated with 6 months mortality (Presence of renal failure)Up to 7 daysnumber od day(s) under renal replacement therapy
Clinical evolutionDay 3Change in Sequential Organ Failure score between Day 1 and Day 3. We measured the Sepsis-related Organ Failure Assessment (SOFA) score at day and day 3 and then made the difference between the two scores the SOFA score could range between 0 and 24 We calculated the score at day 1 and day 3 and made the difference An absence or a small difference between the 2 days is associated with a worse outcome
factors associated with 6 months mortality (Presence of respiratory failure)Up to 7 daysnumber of day(s) under mechanical ventilation

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026